20,000 Kenyans Among Participants of Ksh72.5 Billion Vaccine Trial
A new tuberculosis (TB) vaccine candidate, M72/AS01E, has entered Phase III clinical trials, with Kenyans among the 20,000 global participants ...
Tag: TB Vaccine
A new tuberculosis (TB) vaccine candidate, M72/AS01E, has entered Phase III clinical trials, with Kenyans among the 20,000 global participants ...